The 100,000 Genomes Project, coordinated by Genomics England, will begin soon, with the first full samples being taken in early 2015. Recruitment to the project will be handled by NHS England. What are the aims of the project, and who will benefit from it?
A panel of experts came to the SMC to discuss:
How did the pilot sequencing projects go?
Which NHS Trusts will be designated genomic medicine centres, and why?
What will actually happen at the genomic medicine centres?
Which diseases / patients will be sequenced?
How much will it cost?
How will data be collected and stored?
What about data security?
Who can use the data – academia and / or pharmaceutical companies?
What about insurance companies?
What is the potential for the project to advance healthcare and treatment development?
George Freeman MP, Minister for Life Sciences
Sir Bruce Keogh, Medical Director, NHS England
Prof Sue Hill, Chief Scientific Officer, NHS England
Dr Mark Caulfield, Chief Scientist, Genomics England
in this section
filter Briefings by year
search by tag
This website uses only necessary cookies, to improve your experience. Read MoreAccept
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.